ZyVersa Therapeutics Inc. (NASDAQ: ZVSA) stock fell -0.33% on Friday to $0.15 against a previous-day closing price of $0.15. With 5.89 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.69 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1490 whereas the lowest price it dropped to was $0.1239. The 52-week range on ZVSA shows that it touched its highest point at $25.00 and its lowest point at $0.11 during that stretch. It currently has a 1-year price target of $2.50. Beta for the stock currently stands at 0.35.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ZVSA was up-trending over the past week, with a rise of 18.25%, but this was down by -6.87% over a month. Three-month performance dropped to -54.85% while six-month performance fell -92.55%. The stock lost -98.50% in the past year, while it has lost -90.51% so far this year. A look at the trailing 12-month EPS for ZVSA yields -7.19 with Next year EPS estimates of -0.56. For the next quarter, that number is -0.16. This implies an EPS growth rate of -198.60% for this year and 84.70% for next year.
Float and Shares Shorts:
At present, 36.39 million ZVSA shares are outstanding with a float of 25.40 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.29 million, which was 0.93% higher than short shares on Jul 30, 2023. In addition to Mr. Stephen C. Glover as the firm’s Co-Founder, Chairman, CEO & Pres, Mr. Peter Wolfe serves as its CFO & Sec..
Through their ownership of 27.97% of ZVSA’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.28% of ZVSA, in contrast to 4.74% held by mutual funds. Shares owned by individuals account for 0.28%. As the largest shareholder in ZVSA with 6.59% of the stake, L1 Capital Global, Inc. holds 2,034,933 shares worth 2,034,933. A second-largest stockholder of ZVSA, Virtu Financial BD LLC, holds 120,377 shares, controlling over 0.39% of the firm’s shares. Cowen & Co. LLC is the third largest shareholder in ZVSA, holding 50,000 shares or 0.16% stake. With a 0.16% stake in ZVSA, the RiverNorth Opportunities Fund Inc is the largest stakeholder. A total of 48,471 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.06% of ZVSA stock, is the second-largest Mutual Fund holder. It holds 17,194 shares valued at 2442.0. EHP Global Arbitrage Alternative holds 0.06% of the stake in ZVSA, owning 17,126 shares worth 2432.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, ZVSA reported revenue of $0.00 and operating income of -$1.88M. The EBITDA in the recently reported quarter was -$1.88M and diluted EPS was -$0.10.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ZVSA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ZVSA analysts setting a high price target of $2.50 and a low target of $2.50, the average target price over the next 12 months is $2.50. Based on these targets, ZVSA could surge 1566.67% to reach the target high and rise by 1566.67% to reach the target low. Reaching the average price target will result in a growth of 1566.67% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded ZVSA stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 3,565,310 while 0 shares were sold.